Improvements in Signs and Symptoms During Hospitalization for Acute Heart Failure Follow Different Patterns and Depend on the Measurement Scales Used: An International, Prospective Registry to Evaluate the Evolution of Measures of Disease Severity in Acute Heart Failure (MEASURE-AHF)

被引:35
作者
Allen, Larry A. [1 ]
Metra, Marco [2 ]
Milo-Cotter, Olga [3 ]
Filippatos, Gerasimos [4 ]
Reisin, Leonardo H. [5 ]
Bensimhon, Daniel R. [6 ]
Gronda, Edoardo G. [7 ]
Colombo, Paolo [8 ]
Felker, G. Michael [3 ]
Cas, Livio Dei [2 ]
Kremastinos, Dimitrios T. [4 ]
O'Connor, Christopher M.
Cotter, Gadi [9 ]
Davison, Beth A. [9 ]
Dittrich, Howard C. [10 ]
Velazquez, Eric J. [3 ]
机构
[1] Univ Colorado Denver, Div Cardiol, Aurora, CO USA
[2] Univ Brescia, Dept Expt & Appl Med, Sect Cardiovasc Dis, Brescia, Italy
[3] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
[4] Univ Hosp Attikon, Dept Cardiol, Athens, Greece
[5] Barzilai Govt Hosp, Dept Cardiol, Ashqelon, Israel
[6] Moses Cone Hlth Syst, Greensboro, NC USA
[7] Ist Clin Humanitas, Clin Cardiol & Heart Failure Unit, Rozzano, Italy
[8] Columbia Univ, Med Ctr, Dept Med, New York, NY USA
[9] Momentum Res Inc, Durham, NC USA
[10] Sequel Pharmaceut, San Diego, CA USA
关键词
Congestive heart failure; exacerbation; dyspnea; physical examination; treatment outcome; end point determination;
D O I
10.1016/j.cardfail.2008.07.188
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The natural evolution of signs and symptoms during acute heart failure (AFF) is poorly characterized. Methods and Results: We followed a prospective international cohort of 182 patients hospitalized with AHF. Patient-reported dyspnea and general well-being (GWB) were measured daily using 7-tier Likert (-3 to +3) and visual analog scales (VAS, 0-100). Physician assessments were also recorded daily. Mean age was 69 years and 68% had ejection fraction <40%. Likert Measures of dyspnea initially improved rapidly (day 1, 0.22; day 2, 1.31: P < .001) with no significant improvement therafter (day 7, 1.51: day 2 versus 7 P = .16). In contrast, VAS measure of dyspnea improved throughout hospitalization (day 1, 50.1; day 2, 64.7: day 7, 83.2: day 1 versus 2 P < .001, day 2 versus 7 P < .001). Symptoms of dyspnea and GWB tracked closely (correlation r = .813 P < .001). Physical signs resolved more completely than did symptoms (eg, from day 1 to discharge/day 7, absence of edema increased from 33% to 72% of patients, whereas significant improvements in dyspnea increased from 27% to 52% of patients: P < .001). Conclusions: Changes in patient-reported symptoms and physician-assessed signs followed different patterns during an AHF episode and are influenced by the measurement scales used. Multiple clinical measures should be considered in discharge decisions and evaluation of AHF therapies. (J Cardiac Fail 2008:14:777-784)
引用
收藏
页码:777 / 784
页数:8
相关论文
共 32 条
[1]   Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[2]   Management of acute decompensated heart failure [J].
Allen, Larry A. ;
O'Connor, Christopher M. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (06) :797-805
[3]   Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study [J].
Burger, AJ ;
Horton, DP ;
LeJemtel, T ;
Ghali, JK ;
Torre, G ;
Dennish, G ;
Koren, M ;
Dinerman, J ;
Silver, M ;
Cheng, ML ;
Elkayam, U .
AMERICAN HEART JOURNAL, 2002, 144 (06) :1102-1108
[4]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[5]   Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. [J].
Colucci, WS ;
Elkayam, U ;
Horton, DP ;
Abraham, WT ;
Bourge, RC ;
Johnson, AD ;
Wagoner, LE ;
Givertz, MM ;
Liang, CS ;
Neibaur, M ;
Haught, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :246-253
[6]   Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure [J].
Costanzo, Maria Rosa ;
Guglin, Maya E. ;
Saltzberg, Mitchell T. ;
Jessup, Mariell L. ;
Bart, Bradley A. ;
Teerlink, John R. ;
Jaski, Brian E. ;
Fang, James C. ;
Feller, Erika D. ;
Haas, Garrie J. ;
Anderson, Allen S. ;
Schollmeyer, Michael P. ;
Sobotka, Paul A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (06) :675-683
[7]   Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial [J].
Cuffe, MS ;
Califf, RM ;
Adams, KF ;
Benza, R ;
Bourge, R ;
Colucci, WS ;
Massie, BM ;
O'Connor, CM ;
Pina, I ;
Quigg, R ;
Silver, MA ;
Georghiade, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (12) :1541-1547
[8]   Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure [J].
Drazner, MH ;
Rame, JE ;
Stevenson, LW ;
Dries, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (08) :574-581
[9]   Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure - Results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial [J].
Gattis, WA ;
O'Connor, CM ;
Gallup, DS ;
Hasselblad, V ;
Gheorghiade, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (09) :1534-1541
[10]   Acute heart failure syndromes -: Current state and framework for future research [J].
Gheorghiade, M ;
Zannad, F ;
Sopko, G ;
Klein, L ;
Piña, IL ;
Konstam, MA ;
Massie, BM ;
Roland, E ;
Targum, S ;
Collins, SP ;
Filippatos, G ;
Tavazzi, L .
CIRCULATION, 2005, 112 (25) :3958-3968